NASDAQENSC

Business

Ensysce rallies 22% on FDA update for overdose-resistant opioid (NASDAQ:ENSC)

iQoncept/iStock via Getty Images Ensysce Biosciences (NASDAQ:ENSC) stock closed 22% higher Tuesday after the company said it had received FDA…

Read More »
Back to top button